Cargando…
Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182006/ https://www.ncbi.nlm.nih.gov/pubmed/30310090 http://dx.doi.org/10.1038/s41598-018-32881-6 |
| _version_ | 1783362479229763584 |
|---|---|
| author | Yang, Hai-Yuan Ma, Ding Liu, Yi-Rong Hu, Xin Zhang, Jian Wang, Zhong-Hua Di, Gen-Hong Hu, Xi-Chun Shao, Zhi-Ming |
| author_facet | Yang, Hai-Yuan Ma, Ding Liu, Yi-Rong Hu, Xin Zhang, Jian Wang, Zhong-Hua Di, Gen-Hong Hu, Xi-Chun Shao, Zhi-Ming |
| author_sort | Yang, Hai-Yuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6182006 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61820062018-10-15 Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer Yang, Hai-Yuan Ma, Ding Liu, Yi-Rong Hu, Xin Zhang, Jian Wang, Zhong-Hua Di, Gen-Hong Hu, Xi-Chun Shao, Zhi-Ming Sci Rep Author Correction Nature Publishing Group UK 2018-10-12 /pmc/articles/PMC6182006/ /pubmed/30310090 http://dx.doi.org/10.1038/s41598-018-32881-6 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Yang, Hai-Yuan Ma, Ding Liu, Yi-Rong Hu, Xin Zhang, Jian Wang, Zhong-Hua Di, Gen-Hong Hu, Xi-Chun Shao, Zhi-Ming Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer |
| title | Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer |
| title_full | Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer |
| title_fullStr | Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer |
| title_full_unstemmed | Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer |
| title_short | Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer |
| title_sort | author correction: impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in her2-positive metastatic breast cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182006/ https://www.ncbi.nlm.nih.gov/pubmed/30310090 http://dx.doi.org/10.1038/s41598-018-32881-6 |
| work_keys_str_mv | AT yanghaiyuan authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT mading authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT liuyirong authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT huxin authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT zhangjian authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT wangzhonghua authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT digenhong authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT huxichun authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer AT shaozhiming authorcorrectionimpactofhormonereceptorstatusanddistantrecurrencefreeintervalonsurvivalbenefitsfromtrastuzumabinher2positivemetastaticbreastcancer |